Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexa-Polyspectran with dexamethasone versus Dexa-Polyspectran without dexamethasone for acute bacterial otitis externa
2005-001179-36Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone + neomycin + polymyxin B, dexamethasone sodium phosphate, neomycin and polymyxin B in Acute bacterial otitis externa (AOE) (2 arms), sponsored by Alcon Inc. Started Jul 2005; status: completed.
02
Drugs
dexamethasone + neomycin + polymyxin Bdexamethasone sodium phosphateneomycinpolymyxin B
03
Conditions
Acute bacterial otitis externa (AOE)
Beyond the preview
Go deeper on 2005-001179-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001179-36.